Background The purpose of this study was to present our experience utilizing cetuximab and
platinum‐based concurrent chemoradiotherapy for the definitive treatment of head and neck …

Purpose The role of cetuximab in the treatment of locoregionally advanced head and neck
squamous cell cancer (LA-HNSCC) remains poorly defined. In this phase 2 randomized …

Purpose The combination of cisplatin and radiation or cetuximab and radiation improves
overall survival of patients with locoregionally advanced head and neck carcinoma. NRG …

English Purpose To investigate the effect of adding concurrent chemotherapy (CT) to
cetuximab plus radiotherapy (RT; CT-cetux-RT) compared with cetuximab plus RT (cetux …

Background The addition of cisplatin or cetuximab to radiation therapy (RT) improves
outcomes in comparison with RT alone in the nonoperative management of head and neck …

Background We conducted a multinational, randomized study to compare radiotherapy
alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal …

PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …

5519 Background: Cetuximab is commonly used in combination with either chemotherapy or
radiation in the treatment of HNC, although the optimal way to integrate cetuximab with …

Combining cetuximab with chemoradiotherapy in locally advanced head and neck squamous
cell carcinoma: is more better? - Abstract - Europe PMC Sign in | Create an account …

5529 Background: We previously reported results of a phase 2 study of concurrent
cetuximab, a chimeric monoclonal antibody directed against the epidermal growth factor …